Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction

Joanna L. Stanley, Irene J. Andersson, Cassandra J. Hirt, Linn Moore, Mark R. Dilworth, Alejandro R. Chade, Colin P. Sibley, Sandra T. Davidge, Philip N. Baker

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Fetal growth restriction (FGR) greatly increases the risk of perinatal morbidity and mortality and is associated with increased uterine artery resistance and levels of oxidative stress. There are currently no available treatments for this condition. The hypothesis that the antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol) would improve uterine artery function and rescue fetal growth was tested in a mouse model of FGR, using the endothelial nitric oxide synthase knockout mouse (Nos3-/-). Pregnant Nos3-/- and control C57BL/6J mice were treated with the superoxide dismutase-mimetic Tempol (1 mmol/L) or vehicle from Gestational Day 12.5 to 18.5. Tempol treatment significantly increased pup weight (P
    Original languageEnglish
    Pages (from-to)25
    JournalBiology of reproduction
    Volume87
    Issue number1
    DOIs
    Publication statusPublished - Jul 2012

    Keywords

    • Intrauterine growth restriction
    • Nitric oxide
    • Oxidative stress
    • Placental transport
    • Pregnancy

    Fingerprint

    Dive into the research topics of 'Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction'. Together they form a unique fingerprint.

    Cite this